← Eichor
Study identifier: NCT05903950 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Air Pollution and Cardiovascular Disease in Qatar: an Interventional Study to Reduce Blood Pressure

Condition: Hypertension, Systolic · Metabolic Syndrome  ·  Sponsor: Weill Cornell Medical College in Qatar

PhaseNA
Planned participants100
Who can joinAll sexes, 18 Years to 60 Years
Healthy volunteersNo

About this study

The main objective is to determine if in-home portable air cleaners provide persistent reductions in PM2.5 exposures and improvements in systolic blood pressure and biochemical parameters over 4-weeks in patients with metabolic syndrome residing in Qatar.

This description comes directly from the study's public registry record.

Talk to the study team

Charbel Abi Khalil, MD  ·  +974 4492 8484  ·  cha2022@qatar-med.cornell.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Hamad Medical CorporationDoha, QatarRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05903950